Innovative clinical trials focusing on hormone-positive breast cancer patients at high risk of relapse. The research explores the effectiveness of combining everolimus with standard endocrine therapy for improved disease-free survival.

Hormone Receptor Positive (ER+) Cancer
HER2-Negative Breast Cancer
Adjuvant Therapy

This research aims to enhance treatment outcomes for breast cancer survivors through targeted therapeutic approaches.

02 Colorectal Oncology

Groundbreaking research in colon cancer treatment strategies, specifically targeting stage II patients. The study utilizes innovative circulating tumor DNA analysis to guide adjuvant treatment decisions.

Stage II Colon Cancer
Circulating Tumor DNA Analysis
FOLFOX Therapy

This precision medicine approach aims to improve disease-free survival rates through personalized treatment selection.

Back to France All countries

Clinical trials in Montélimar

5 trials in Montélimar

Colon cancer

Study on Using Oxaliplatin, Fluorouracil, and Folinic Acid for Treating Stage II Colon Cancer in Patients with Positive Circulating Tumor DNA

Ischaemic stroke

Effectiveness of Tenecteplase in Acute Ischemic Stroke Patients Treated 4.5–24 Hours After Onset Before Transfer for Thrombectomy

Pneumonia+1

Early Use of Dexamethasone versus Sodium Chloride Placebo in Patients with Severe Influenza-Induced Acute Hypoxemic Respiratory Failure (Phase III Randomized Trial)

Colon cancer

Study on Chemotherapy with Levoleucovorin, Capecitabine, and Folinic Acid for Patients Aged 70+ After Stage III Colon Cancer Surgery

Hormone receptor positive HER2 negative breast cancer

Title: Study of everolimus with hormone therapy in women with high-risk breast cancer (ER-positive, HER2-negative) who are disease-free after initial treatment

Filter the trials

Other cities in France

Clinical research in Montélimar

Prefer not to search? Our Concierge searches the trials for you.